These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
    Author: Tsaoussis V, Vakirtzi-Lemonias C.
    Journal: J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789.
    Abstract:
    Mouse plasma platelet-activating factor acetylhydrolase (PAF-AH) has an apparent Km of 7.4 microM and a Vmax of 21.6 nmol/min per mg protein. Comparison with values reported for the human and the rat enzymes shows at least a 5-fold higher Vmax and similar enzyme-substrate affinity. Although lecithin:cholesterol acyltransferase (LCAT) and one component of the PAF-AH share similar masses and lipoprotein association, they are distinct enzymes. Similarly, PAF-AH is distinct from the phospholipase A2 (PLA2) and the lysophospholipase of mouse plasma. A series of PAF structural analogs showed either competitive inhibition or a mixed type of inhibition of PAF-AH. Mouse plasma PAF-AH is highly sensitive to 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) and is activated by deoxycholate. SDS-PAGE showed that two distinct proteins with molecular masses of 46 and 63 kDa contribute to the PAF-AH activity. The HDL-VHDL lipoprotein associated PAF-AH is precipitated to an extent of about 60% by phosphotungstate-MgCl2 and Tween 20 only partially solubilises the precipitated enzyme under conditions which can precipitate and solubilise the human enzyme.
    [Abstract] [Full Text] [Related] [New Search]